Isolation of HL-A 33,000-dalton fragments carrying high HL-A alloantigenic activity.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 50658)

Published in Transplantation on May 01, 1975

Authors

K Nakamuro, N Tanigaki, D Pressman

Articles by these authors

The Zone of Localization of Anti-Mouse-Kidney Serum as Determined by Radioautographs. Science (1949) 8.12

A SIMPLIFIED LYOPHIL APPARATUS. Science (1944) 4.56

Immunological dissection of human Ia molecules. J Exp Med (1978) 2.93

Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc Soc Exp Biol Med (1967) 2.47

Number of binding sites of rabbit macroglobulin antibody and its subunits. Immunochemistry (1965) 2.16

Multiple common properties of human beta2-microglobulin and the common portion fragment derived from HL-A antigen molecules. Proc Natl Acad Sci U S A (1973) 2.08

Evidence that celiac disease is primarily associated with a DC locus allelic specificity. Clin Immunol Immunopathol (1983) 2.02

Subsets of human Ia-like molecules defined by monoclonal antibodies. Mol Immunol (1981) 1.87

Serological Reactions with Simple Substances Containing Two or More Haptenic Groups. Proc Natl Acad Sci U S A (1941) 1.60

IgM and IgG anti-hapten antibody: hemolytic, hemagglutinating and precipitating activity. Proc Soc Exp Biol Med (1965) 1.55

Molecular identification of human Ia antigens coded for by a gene locus closely linked to HLA-DR locus. Immunogenetics (1980) 1.48

Immunoglobulin production in human leukemia cell lines. J Immunol (1966) 1.47

Immunoadsorbents with high capacity. Immunochemistry (1965) 1.39

The genetic control of human Ia alloantigens: a three-loci model derived from the immunochemical analysis of 'supertypic' specificities. Immunol Rev (1982) 1.39

Isolation of rabbit IgA antihapten antibody and demonstration of skin-sensitizing activity in homologous skin. J Exp Med (1966) 1.37

Immunoglobulin production in synchronized cultures of human hematopoietic cell lines. I. Variation of cellular immunoglobulin level with the generation cycle. J Immunol (1969) 1.36

Characterization of soluble substances in plasma carrying HL-A alloantigenic activity and HL-A common antigenic activity. Transplantation (1973) 1.35

Absence of reaction of a xenogenic anti-H-2 serum with mouse embryonal carcinoma cells. Transplantation (1978) 1.29

HL-A antigens from hematopoietic cell lines: molecular size and electrophoretic mobility. J Immunol (1971) 1.28

Change in antibody conformation induced by hapten. Proc Natl Acad Sci U S A (1965) 1.27

Radioiodinated soluble HL-A antigens: HL-A alloantigenic characterization and use in radioimmunoassay. J Immunol Methods (1973) 1.26

Isolation and characterization of free gamma chain of immunoglobulin produced by an established cell line of human myeloma cell origin. I. Gamma chain in culture medium. J Immunol (1969) 1.23

Alloantigens of human lymphoid cell lines; 'human Ia-like antigens'. Alloantigenic activity and cell line, organ and tissue distribution as determined by radioimmunoassay. Immunology (1977) 1.23

Partial amino acid sequence of mouse beta2-microglobulin. Biochem Biophys Res Commun (1976) 1.20

The 11,000-dalton component of mouse H-2. Isolation and identification. Transplantation (1974) 1.19

The effects of complete modification of amino groups on the antibody activity of antihapten antibodies. Reversible inactivation with maleic anhydride. Biochemistry (1968) 1.19

The component fragments obtained by acid dissociation of papain-solubilized H-2 molecules. J Immunogenet (1976) 1.18

Immunoglobulin M antibodies with ten combining sites. Science (1968) 1.18

An efficient method for isolation of HL-A antigens from hematopoietic cell lines. J Immunol (1971) 1.18

A mouse plasma substance carrying beta2-microglobulin activity and lacking in H-2 alloantigenic activity. J Immunogenet (1976) 1.17

The basic structure and the antigenic characteristics of HL-A antigens. Transplant Rev (1974) 1.14

Binding of one monoclonal antibody to human Ia molecules can be enhanced by a second monoclonal antibody. Eur J Immunol (1981) 1.11

Absence of a serologically detectable association of murine beta2-microglobulin with the embryonic F9 antigen. Transplantation (1976) 1.11

Immunoglobulin production in cloned sublines of a human lymphocytoid cell line. J Immunol (1969) 1.11

Human Ia-like antigens in non-lymphoid organs. Immunology (1979) 1.10

Monoclonal IgA and IgM in the serum of a single patient (SC). I. Sharing of individually specific determinants between IgA and IgM. J Immunol (1973) 1.10

Three Ia species with different structures and alloantigenic determinants in an HLA-homozygous cell line. J Exp Med (1983) 1.10

The sequence around the active-center tyrosyl residue of bovine pancreatic carboxypeptidase A. Proc Natl Acad Sci U S A (1967) 1.10

Amino acid sequence of the light chain derived from a rabbit anti-p-azobenzoate antibody of restricted heterogeneity. Biochem Biophys Res Commun (1973) 1.09

Common antigenic structures of HL-A antigens. VI. Common antigenic determinants located on the 33,000 Dalton alloantigenic fragment portion of papain-solubilized HL-A molecules. Immunology (1975) 1.07

Common antigen structures of HL-A antigens. I. Antigenic determinants recognizable by rabbits on papain-solubilized HL-A molecular fragments. Immunology (1973) 1.06

A radioimmunoassay typing study of non-DQw2-associated celiac disease. Clin Immunol Immunopathol (1986) 1.06

Common antigenic structures of HL-A antigens. II. Small fragments derived from papain-solubilized HL-A antigen molecules. Immunology (1974) 1.05

Further studies on Th-B, a cell surface antigenic determinant present on mouse B cells, plasma cells and immature thymocytes. Cell Immunol (1976) 1.05

Human transplantation antigens: isolation and radioimmunoassay. Proc Soc Exp Biol Med (1971) 1.05

Comparative studies of chromosomal aberration induced by trivalent and pentavalent arsenic. Mutat Res (1981) 1.04

A surface membrane determinant shared by subpopulations of thymocytes and B lymphocytes. J Immunol (1975) 1.04

Application of the paired label radioantibody technique to tissue sections and cell smears. J Immunol (1967) 1.04

Common antigenic structures of HL-A antigens. IV. HL-A common portion fragment isolated from spent culture medium of human lymphoid cell lines. Immunology (1974) 1.03

Modification of arginine in the active sites of antibodies. Biochemistry (1968) 1.02

Antibodies of limited heterogeneity: L chains of a single mobility. Immunochemistry (1970) 1.02

The expression on mouse lymphoid cells of Th-B, an antigen common to mouse B cells and thymus cells. J Immunol (1975) 1.01

Presence of two different immunoglobulin heavy chains in individual cells of established human hematopoietic cell lines. J Immunol (1968) 1.01

Separation of antibodies into fractions with different binding properties. Immunochemistry (1967) 1.00

Experimental anti-alveolar basement membrane antibody-mediated pneumonitis. I. The role of increased permeability of the alveolar capillary wall induced by oxygen. J Immunol (1981) 1.00

Receptor-blocking factor present in immune serum resembling auto-anti-idiotype antibody. J Immunol (1976) 1.00

Rabbit antiserum against a non-T, non-B leukemia cell line that carries the Ph1 chromosome (NALM-1): antibody specific to a non-T, non-B acute lymphoblastic leukemia antigen. J Natl Cancer Inst (1978) 0.99

Spreading of HIV-specific CD8+ T-cell repertoire in long-term nonprogressors and its role in the control of viral load and disease activity. Hum Immunol (2001) 0.98

Antibody against neoplastic plasma cells. I. Specific surface antigens on mouse myeloma cells. J Immunol (1971) 0.98

Determination of HL-A zygosity by radioimmunoassay. Transplantation (1972) 0.98

Monoclonal IgA and IgM in the serum of a single patient (SC). 3. Immunofluorescent identification of cells producing IgA and IgM. J Immunol (1973) 0.97

Human cell membrane components bound to beta2-microglobulin in T cell-type cell lines. J Immunol (1978) 0.97

Amino acid composition and physicochemical properties of mouse beta2-microglobulin. Biochem Biophys Res Commun (1975) 0.97

Preferential recombination of antibody chains to form effective binding sites. J Exp Med (1965) 0.96

HLA-DR typing by radioimmunoassay. Transplantation (1980) 0.96

A cell surface antigenic determinant present on mouse plasmacytes and only about half of mouse thymocytes. J Immunol (1974) 0.94

Common antigenic structures of HL-A antigens. V. An antigenic determinant characteristic of a 33,000-dalton fragment of HL-A molecules. Transplantation (1974) 0.94